132 related articles for article (PubMed ID: 24684490)
41. Sonication-assisted Layer-by-Layer self-assembly nanoparticles for resveratrol delivery.
Santos AC; Sequeira JAD; Pereira I; Cabral C; Collado Gonzallez M; Fontes-Ribeiro C; Ribeiro AJ; Lvov YM; Veiga FJ
Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110022. PubMed ID: 31546400
[TBL] [Abstract][Full Text] [Related]
42. Suppressing unspecific cell uptake for targeted delivery using hydroxyethyl starch nanocapsules.
Baier G; Baumann D; Siebert JM; Musyanovych A; Mailänder V; Landfester K
Biomacromolecules; 2012 Sep; 13(9):2704-15. PubMed ID: 22844871
[TBL] [Abstract][Full Text] [Related]
43. The dissolution enhancement of piroxicam in its physical mixtures and solid dispersion formulations using gluconolactone and glucosamine hydrochloride as potential carriers.
Al-Hamidi H; Obeidat WM; Nokhodchi A
Pharm Dev Technol; 2015 Jan; 20(1):74-83. PubMed ID: 24392858
[TBL] [Abstract][Full Text] [Related]
44. Box-Behnken optimization design and enhanced oral bioavailability of thymopentin-loaded poly (butyl cyanoacrylate) nanoparticles.
Jin X; Huang A; Ping Q; Cao F; Su Z
Pharmazie; 2011 May; 66(5):339-47. PubMed ID: 21699067
[TBL] [Abstract][Full Text] [Related]
45. Controlled release of dexamethasone from microcapsules produced by polyelectrolyte layer-by-layer nanoassembly.
Pargaonkar N; Lvov YM; Li N; Steenekamp JH; de Villiers MM
Pharm Res; 2005 May; 22(5):826-35. PubMed ID: 15906179
[TBL] [Abstract][Full Text] [Related]
46. Preparation and study of poly(vinyl acetate) and poly(styrene) nanosized latex with indometacin.
Andonova V; Georgiev G; Toncheva V; Kassarova M
Pharmazie; 2012 Jul; 67(7):601-4. PubMed ID: 22888516
[TBL] [Abstract][Full Text] [Related]
47. Influence of cyclodextrin complexation on piroxicam gel formulations.
Jug M; Bećirević-Laćan M; Kwokal A; Cetina-Cizmek B
Acta Pharm; 2005 Sep; 55(3):223-36. PubMed ID: 16375834
[TBL] [Abstract][Full Text] [Related]
48. Nanocolloids of indomethacin prepared using sonication and subsequent encapsulation with polysaccharide films.
Milkova V; Kamburova K; Radeva T
Colloids Surf B Biointerfaces; 2013 Aug; 108():279-84. PubMed ID: 23563295
[TBL] [Abstract][Full Text] [Related]
49. Dissolution enhancement and formulation of rapid-release lornoxicam mini-tablets.
Tawfeek HM; Saleem IY; Roberts M
J Pharm Sci; 2014 Aug; 103(8):2470-83. PubMed ID: 24995853
[TBL] [Abstract][Full Text] [Related]
50. Studies on the characteristics of drug-loaded gelatin nanoparticles prepared by nanoprecipitation.
Lee EJ; Khan SA; Park JK; Lim KH
Bioprocess Biosyst Eng; 2012 Jan; 35(1-2):297-307. PubMed ID: 21909678
[TBL] [Abstract][Full Text] [Related]
51. Influence of cellulose derivative and ethylene glycol on optimization of lornoxicam transdermal formulation.
Shahzad Y; Khan Q; Hussain T; Shah SN
Int J Biol Macromol; 2013 Oct; 61():26-32. PubMed ID: 23827761
[TBL] [Abstract][Full Text] [Related]
52. Encapsulation of rifampin in a polymeric layer-by-layer structure for drug delivery.
Esmaeili A; Khodaei M
J Biomed Mater Res A; 2018 Apr; 106(4):905-913. PubMed ID: 29143479
[TBL] [Abstract][Full Text] [Related]
53. pH sensitive silica nanotubes as rationally designed vehicles for NSAIDs delivery.
Sousa CT; Nunes C; Proença MP; Leitão DC; Lima JL; Reis S; Araújo JP; Lúcio M
Colloids Surf B Biointerfaces; 2012 Jun; 94():288-95. PubMed ID: 22366067
[TBL] [Abstract][Full Text] [Related]
54. Effect of glucosamine HCl on dissolution and solid state behaviours of piroxicam upon milling.
Al-Hamidi H; Edwards AA; Douroumis D; Asare-Addo K; Nayebi AM; Reyhani-Rad S; Mahmoudi J; Nokhodchi A
Colloids Surf B Biointerfaces; 2013 Mar; 103():189-99. PubMed ID: 23201737
[TBL] [Abstract][Full Text] [Related]
55. New solid lipid microparticles for controlled ibuprofen release: formulation and characterization study.
Perge L; Robitzer M; Guillemot C; Devoisselle JM; Quignard F; Legrand P
Int J Pharm; 2012 Jan; 422(1-2):59-67. PubMed ID: 22027394
[TBL] [Abstract][Full Text] [Related]
56. Preparation and Characterization of Whey Protein Isolate-DIM Nanoparticles.
Khan A; Wang C; Sun X; Killpartrick A; Guo M
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31408980
[TBL] [Abstract][Full Text] [Related]
57. Entrapment and release kinetics of furosemide from pegylated nanocarriers.
Youm I; Murowchick JB; Youan BB
Colloids Surf B Biointerfaces; 2012 Jun; 94():133-42. PubMed ID: 22386795
[TBL] [Abstract][Full Text] [Related]
58. Electrospray fabrication of doxorubicin-chitosan-tripolyphosphate nanoparticles for delivery of doxorubicin.
Songsurang K; Praphairaksit N; Siraleartmukul K; Muangsin N
Arch Pharm Res; 2011 Apr; 34(4):583-92. PubMed ID: 21544723
[TBL] [Abstract][Full Text] [Related]
59. Formulation and characterization of solid lipid nanoparticles, nanostructured lipid carriers and nanoemulsion of lornoxicam for transdermal delivery.
Gönüllü Ü; Üner M; Yener G; Karaman EF; Aydoğmuş Z
Acta Pharm; 2015 Mar; 65(1):1-13. PubMed ID: 25781700
[TBL] [Abstract][Full Text] [Related]
60. Effect of solvents on forming poly(butyl-2-cyanoacrylate) encapsulated paeonol nanocapsules.
Yao J; Zeng D; Zhang Y; Sun D; Yang E; Liu H; Guo F; Wang W
J Biomater Sci Polym Ed; 2017 Feb; 28(3):240-256. PubMed ID: 27846779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
